Epigenetic challenges on the horizon of chimeric antigen receptor-T

被引：0
|
作者：
Benincasa, Giuditta [1 ]
Strozziero, Maria Grazia [2 ]
Pastena, Maria Assunta Di [3 ]
Criscuolo, Clelia [4 ]
Cetani, Giusy [5 ]
Trama, Ugo [6 ]
Napoli, Claudio [1 ,3 ]
机构：
[1] Univ Campania Luigi Vanvitelli, Dept Adv Med & Surg Sci DAMSS, I-80138 Naples, Italy
[2] IRCCS SYNLAB SDN, Naples, Italy
[3] Univ Campania Luigi Vanvitelli, Dept Internal Med & Specialist, UOC Div Clin Immunol Immunohematol Transfus Med &, Naples, Italy
[4] Hosp Aversa ASLCE, Div Hematol, Aversa, Italy
[5] Antonio Cardarelli Hosp, Div Hematol, Naples, Italy
[6] Reg Pharmaceut Unit, Naples, Campania Region, Italy
来源：
CYTOTHERAPY | 2024年 / 26卷 / 05期
关键词：
D O I：
10.1016/j.jcyt.2024.02.016
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
引用
收藏
页码：411 / 412
页数：2
相关论文
共 50 条
  • [1] Challenges and interventions of chimeric antigen receptor-T cell therapy in solid tumors
    Shasha Liu
    Yi Zhang
    Chinese Journal of Cancer Research, 2023, 35 (03) : 239 - 244
  • [2] Challenges and interventions of chimeric antigen receptor-T cell therapy in solid tumors
    Liu, Shasha
    Zhang, Yi
    CHINESE JOURNAL OF CANCER RESEARCH, 2023, 35 (03) : 239 - 244
  • [3] Chimeric Antigen Receptor-T Cells: A Pharmaceutical Scope
    Hernandez-Lopez, Alejandrina
    Tellez-Gonzalez, Mario A.
    Mondragon-Teran, Paul
    Meneses-Acosta, Angelica
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [4] Chimeric antigen receptor-t cells (CAR-T) horizon scanning: Emerging targets in oncology and hematology
    Dardonville, Quentin
    Davoine, Claire
    Dahan, Muriel
    Grosjean, Ghislain
    Bermudez, Elisabeth
    Ifrah, Norbert
    Negellen, Sophie
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [5] Chimeric Antigen Receptor-T Cells for Targeting Solid Tumors: Current Challenges and Existing Strategies
    Lorraine Springuel
    Caroline Lonez
    Bertrand Alexandre
    Eric Van Cutsem
    Jean-Pascal H. Machiels
    Marc Van Den Eynde
    Hans Prenen
    Alain Hendlisz
    Leila Shaza
    Javier Carrasco
    Jean-Luc Canon
    Mateusz Opyrchal
    Kunle Odunsi
    Sylvie Rottey
    David E. Gilham
    Anne Flament
    Frédéric F. Lehmann
    BioDrugs, 2019, 33 : 515 - 537
  • [6] Engineering chimeric antigen receptor-T cells for cancer treatment
    Ye, Baixin
    Stary, Creed M.
    Li, Xuejun
    Gao, Qingping
    Kang, Chunsheng
    Xiong, Xiaoxing
    MOLECULAR CANCER, 2018, 17
  • [7] Chimeric Antigen Receptor-T Cells for Targeting Solid Tumors: Current Challenges and Existing Strategies
    Springuel, Lorraine
    Lonez, Caroline
    Alexandre, Bertrand
    Van Cutsem, Eric
    Machiels, Jean-Pascal H.
    Van Den Eynde, Marc
    Prenen, Hans
    Hendlisz, Alain
    Shaza, Leila
    Carrasco, Javier
    Canon, Jean-Luc
    Opyrchal, Mateusz
    Odunsi, Kunle
    Rottey, Sylvie
    Gilham, David E.
    Flament, Anne
    Lehmann, Frederic F.
    BIODRUGS, 2019, 33 (05) : 515 - 537
  • [8] The update of chimeric antigen receptor-T cells therapy in glioblastoma
    Chou, Chi-Jen
    Lin, Chun-Fu
    Chen, Yi-Wei
    Huang, Pin-, I
    Yang, Yi-Ping
    Wang, Mong-Lien
    Hung, Kai-Feng
    Lee, Yi-Yen
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2020, 83 (05) : 442 - 445
  • [9] Chimeric antigen receptor-T cell therapies: The changing landscape
    Sengsayadeth, Salyka M.
    Dholaria, Bhagirathbhai R.
    Savani, Bipin N.
    Oluwole, Olalekan O.
    EJHAEM, 2022, 3 : 3 - 5
  • [10] Engineering chimeric antigen receptor-T cells for cancer treatment
    Baixin Ye
    Creed M. Stary
    Xuejun Li
    Qingping Gao
    Chunsheng Kang
    Xiaoxing Xiong
    Molecular Cancer, 17
12345